- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Insulin Glargine
Total 2834 results
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Mannkind CorporationJaeb Center for Health ResearchActive, not recruitingDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1United States
-
The First Affiliated Hospital of Xiamen UniversityUnknownOverweight and Obesity | Hyperglycaemia (Diabetic) | Type 2 Diabetes PatientsChina
-
Fudan UniversityShanghai Changzheng Hospital; Shanghai 6th People's Hospital; Shanghai Minhang... and other collaboratorsCompletedDiabetes Mellitus, Type 2 | Non-alcoholic Fatty Liver DiseaseChina
-
Nordsjaellands HospitalOdense University Hospital; Zealand University Hospital; Aarhus University Hospital and other collaboratorsCompletedType 1 Diabetes Mellitus | Nocturnal Hypoglycemia | Recurrent Severe HypoglycaemiaDenmark
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusUnited States, Czechia, France, Spain, Japan, Germany, Italy, Brazil, Denmark, Austria, United Kingdom, China, Russian Federation, Mexico, Poland, Ukraine, Israel, Puerto Rico
-
Cliniques universitaires Saint-Luc- Université...CompletedType 1 DiabetesBelgium
-
AstraZenecaEli Lilly and CompanyCompleted
-
Population Health Research InstituteHamilton Health Sciences CorporationCompletedType 2 Diabetes MellitusCanada
-
Emory UniversityCompleted
-
Rush University Medical CenterWithdrawn
-
SanofiCompletedDiabetes Mellitus, Type 2France, Russian Federation, Croatia, Slovenia, Czech Republic, Romania
-
SanofiCompleted
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusFinland, Netherlands, Sweden
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Puerto Rico, Poland, Canada, Austria, Mexico, Denmark, Croatia, Brazil, Argentina, Romania, South Africa, Russian Federation, France, Lithuania
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Completed
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Canada, India, Romania, Spain, Mexico, Turkey, Portugal, Egypt
-
AstraZenecaEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Belgium, United States, Australia, Portugal, Germany, Puerto Rico, Spain, Netherlands, Brazil, Finland, Norway, Poland, Sweden
-
Riverside University Health System Medical CenterTerminated
-
Cairo UniversitySanofiUnknownLiver Cirrhosis | Type 2 DiabetesEgypt
-
Vancouver General HospitalTerminatedPost-Transplant Glucocorticoid Induced DiabetesCanada
-
Institut de Recherches Cliniques de MontrealNovo Nordisk A/S; McMaster UniversityCompleted
-
Emory UniversityCompletedDiabetes Mellitus | Type 1 DiabetesUnited States
-
University Hospital TuebingenWithdrawn
-
SanofiCompletedDiabetes Mellitus, Type 2Brazil, United States, Finland, Spain, Austria, Canada, Czech Republic, France, Greece, Ireland, Israel, Mexico, Netherlands, Russian Federation, Slovakia, Sweden, Turkey
-
Assaf-Harofeh Medical CenterTerminated
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusGermany
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusUnited States
-
SanofiCompleted
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada
-
SanofiCompletedDiabetes MellitusSweden, Finland, Netherlands, United Kingdom
-
Hoffmann-La RocheTerminatedDiabetes Mellitus Type 2China, Hong Kong, Korea, Republic of, Philippines, Taiwan, Malaysia, Thailand
-
University of Colorado, DenverCompletedType 1 Diabetes Mellitus | Diabetic KetoacidosisUnited States
-
Loyola UniversitySanofiCompletedRenal Insufficiency | Type 2 DiabetesUnited States
-
Dr. Muhammad AbdulghaniUnknown
-
Eli Lilly and CompanyCompleted
-
Daiichi Sankyo, Inc.CompletedType 2 DiabetesUnited States
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2China
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States, Puerto Rico
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Germany
-
SanofiCompleted
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Belgium, Hong Kong, United States, Germany, Portugal, Russian Federation, France, Canada, Finland, Austria, New Zealand, Spain, Poland, Thailand, Italy, Serbia, Korea, Republic of, Hungary, Mexico, Greece, Puerto Rico, Gu... and more
-
ikfe-CRO GmbHIKFE Institute for Clinical Research and DevelopmentCompletedType 2 Diabetic Patients | Insufficient Metabolic Control | OAD TreatmentGermany
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedDiabetes MellitusSingapore